Abbvie Inc

General

Total Cases156
Active Cases36
Patents2,009
TypeOperating Company
Elite Ratings
--

Ratings

Experience
Grade
Trend
DCT
L5
E
PTAB
L5
E
CAFC
L5
E

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered
Case
Description
11/15/24
Summons Issued as to Aurobindo Pharma Ltd. on 11/14/2024; Aurobindo Pharma USA, Inc. on 11/14/2024; Hetero Labs Limited on 11/14/2024; Hetero Labs Limited Unit-V on 11/14/2024; Hetero USA, Inc. on 11/14/2024; Hoster Labs Private Limited on 11/14/2024; Sandoz GmbH on 11/14/2024; Sandoz Inc. on 11/14/2024; Sandoz Private Limited on 11/14/2024; Sun Pharmaceutical Industries, Ltd. on 11/14/2024. (Attachments: # [1] Summons Issued to Aurobindo Pharma USA, Inc., # [2] Summons Issued to Hetero Labs Limited Unit-V, # [3] Summons Issued to Hetero Labs Limited, # [4] Summons Issued to Hetero USA, Inc., # [5] Summons Issued to Hoster Labs Private Limited, # [6] Summons Issued to Sandoz GmbH, # [7] Summons Issued to Sandoz Inc., # [8] Summons Issued to Sandoz Private Limited, # [9] Summons Issued to Sun Pharmaceutical Industries, Ltd.)(scs) (Entered: 11/15/2024)
11/15/24
Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by AbbVie Inc.. (scs) (Entered: 11/15/2024)
11/15/24
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,077,545 B2; 12,103,933 B2; 12,110,297 B2; 12,116,373 B2 ; 12,110,298 B2. (scs) (Entered: 11/15/2024)
11/15/24
Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/24/2024. Date of Expiration of Patent: 10/17/2036.Thirty Month Stay Deadline: 2/16/2027. (scs) (Entered: 11/15/2024)
11/15/24
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (scs) (Entered: 11/15/2024)
11/15/24
COMPLAINT against Aurobindo Pharma Ltd., Aurobindo Pharma USA, Inc., Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA, Inc., Hoster Labs Private Limited, Sandoz GmbH, Sandoz Inc., Sandoz Private Limited, Sun Pharmaceutical Industries, Ltd. (Filing fee $ 405, receipt number ADEDC-4548912) - filed by AbbVie Inc.. (Attachments: # [1] Exhibits A-E, # [2] Civil Cover Sheet)(scs). (Entered: 11/15/2024)
10/31/24
SO ORDERED re [21] Stipulation of Dismissal (as to Hoster Labs Private Limited). Party Hoster Labs Private Limited terminated. Signed by Judge Maryellen Noreika on 10/31/2024. (dlw) (Entered: 10/31/2024)
10/30/24
STIPULATION of Dismissal as to Defendant Hoster Labs Private Limited by AbbVie Inc. (Tigan, Jeremy) Modified on 10/31/2024 (dlw). (Entered: 10/30/2024)
10/30/24
ANSWER to [13] Answer to Complaint, Counterclaim by AbbVie Inc..(Tigan, Jeremy) (Entered: 10/30/2024)
10/29/24
FINAL Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,851,504. (vfm) (Entered: 10/29/2024)